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This study reports for the ﬁrst time the biological properties of Portuguese propolis. The antioxidant
potential of propolis samples from Bornes (Northeast) and Fundão (Centre) regions of Portugal was eval-
uated by their ability to inhibit the 2,20-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced oxi-
dative hemolysis and lipid peroxidation in human erythrocytes. Bornes and Fundão propolis strongly
protected the erythrocyte membrane from hemolysis (IC50 of 6.3 ± 0.7 and 10.4 ± 2.7 lg/ml, respectively),
in a time- and concentration-dependent manner. This effect was found to be signiﬁcantly higher than
that presented by ascorbic acid (IC50 of 31.0 ± 5.6 lg/ml). In addition, human erythrocytes treated with
propolis extracts showed concentration-dependent decrease in levels of malondialdehyde, a breakdown
product of lipid peroxidation. Propolis extracts were also assayed for their anticancer properties on
human renal cell carcinoma (RCC). Primary cultures of normal and cancerous renal cells derived from
RCC patients, in addition to A-498 cell line, were treated with propolis extracts (0–100 lg/ml). Cytotoxic
and antiproliferative effects were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide (MTT) assay. Propolis extracts exhibited selective toxicity against malignant cells compared
to normal cells. In vitro RCC growth was strongly inhibited by Bornes and Fundão propolis in a concen-
tration-dependent manner. Our results indicate that Portuguese propolis constitutes an excellent source
of effective natural antioxidant and chemopreventive agents.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Propolis is a complex resinous bee product widely employed in
traditional medicine owed to its plethora of biological activities.
Many in vitro studies have already conﬁrmed its antibacterial
(Scazzocchio et al., 2006), antifungal (Silici et al., 2005), antiviral
(Schnitzler et al., 2010), antiinﬂammatory (Tan-No et al., 2006),
antioxidant (Banskota et al., 2000), hepatoprotective (Banskota
et al., 2001a), cariostatic (Libério et al., 2009), anticancer (Russo
et al., 2004; Orsolic´ et al., 2006), and immunostimulant (Sforcin,
2007) properties. Therefore, propolis has attracted much attention
in recent years as a useful or potential agent with application in
pharmaceutical products and in the food industry for health foods,
beverages and nutritional supplements. Propolis composition isll rights reserved.
ncias da Saúde, Universidade
Porto, Portugal. Tel.: +351very complex. It contains mainly waxes, resin and volatiles. The
main chemical groups present in propolis resin comprise phenolic
acids or their esters, ﬂavonoids (ﬂavones, ﬂavanones, ﬂavonols,
dihydroﬂavonols and chalcones), terpenes, aromatic aldehydes
and alcohols, fatty acids, stilbenes and b-steroids (Marcucci,
1995; Gardana et al., 2007). Biological and therapeutic actions of
propolis are generally attributed to its constituents of plant origin,
mainly phenolics (Burdock, 1998). In the present study, we report
for the ﬁrst time the biological actions of Portuguese propolis, spe-
ciﬁcally its antioxidant and antiproliferative activities.
Flavonoids represent the main group of chemical compounds
present in the European propolis samples and are well-known to
possess antioxidant activity, mainly via their free radical
scavenging activity and metal chelating properties (Perron and
Brumaghim, 2009; Rice-Evans, 2001; Cao et al., 1997). Many stud-
ies have already shown strong antioxidant properties for different
propolis samples using different chemical assays, such as scaveng-
ing of DPPH radical (Izuta et al., 2009; Moreira et al., 2008; Bansko-
ta et al., 2000), scavenging of superoxide anion (Russo et al., 2004),
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of DNA cleavage induced by hydrogen peroxide UV-photolysis
(Russo et al., 2004). Nevertheless, the validation of this effect in hu-
man cell-based model assays is extremely important. Therefore,
the in vitro oxidative damage of human erythrocytes was used in
this study as a model to evaluate the free radical-induced damage
of biological membranes and the protection conferred by the prop-
olis extracts. AAPH was used herein as source of peroxyl radicals to
initiate lipid peroxidation and subsequent hemolysis. As far as we
know, this is the ﬁrst study concerning the antihemolytic activity
of propolis extracts on human erythrocytes.
Moreover, an important point in propolis research refers to its
anticancer properties. Propolis and its phenolic compounds have
been demonstrated to exert protective effect against several types
of cancer, including colon (Banskota et al., 2002; Ishihara et al.,
2009; Usia et al., 2002), pancreatic (Li et al., 2010; Awale et al.,
2008), cervical (Sha et al., 2009), skin (Chen et al., 2004), and lung
(Weng et al., 2007; Li et al., 2008), among others. Several mecha-
nisms contribute to the overall cancer preventive and antitumor
properties of propolis and its phenolic components, including
cell-cycle arrest, induction of apoptosis, and inhibition of cancer
cells proliferation and tumor growth (Orsolic´ et al., 2006; Chen
et al., 2004; Bufalo et al., 2010; Fresco et al., 2006). Although anti-
cancer properties of propolis have been shown in several cancer
types, its effect in renal cell carcinoma (RCC) is hitherto unknown.
Therefore, in this study, the antiproliferative activity of propolis ex-
tracts on primary cultured cancerous renal cells (derived from pa-
tients with kidney cancer) and A-498 cell line was evaluated. In
order to determine whether the extracts exhibit a selective cyto-
toxic effect against cancer cells, an 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) based cytotoxic assay
was carried out using normal renal cells. To our knowledge, this
is the ﬁrst time that the potential use of propolis extracts in che-
moprevention of RCC is evaluated.2. Materials and methods
2.1. Chemicals
2,20-Azobis(2-amidinopropane) dihydrochloride (AAPH), trichloroacetic acid
(TCA), 1,1,3,3-tetraethoxypropane (TEP), thiobarbituric acid (TBA), butylated
hydroxytoluene (BHT), and MTT were purchased from Sigma (St. Louis, MO). Dul-
becco’s modiﬁed Eagle’s medium nutrient mixture F12 Ham (DMEM/F12) Gluta-
Max™-I, RPMI 1640 GlutaMax™-I medium, heat-inactivated fetal bovine serum
(FBS), penicillin–streptomycin, fungizone, human transferring, and trypsin–EDTA
were purchased from Gibco-Invitrogen. All other chemicals were of analytical grade
and obtained from Sigma (St. Louis, MO).
2.2. Samples
Propolis samples were collected by beekeepers in September 2007 from Apis
mellifera hives located in Serra de Bornes in the Northeast of Portugal and in Fundão
(Beira Interior region) in the Centre of Portugal. These propolis samples were frozen
at 20 C until analysis.
2.3. Extraction procedure
Samples were prepared by mixing propolis with methanol (1:1, v/v) and left
over-night in agitation (200 rpm) at room temperature. The obtained solution
was ﬁltered (Whatman n 4 ﬁlter paper) and the residue was re-extracted twice
more under the same conditions. Combined methanolic extracts were then placed
at low temperatures and, after 12 h, ﬁltered to remove wax and evaporated to dry-
ness. The extraction yields in relation to dry matter were 49% and 53% for Bornes
and Fundão samples, respectively.
2.4. Antioxidant activity assessment
2.4.1. Preparation of human erythrocyte suspensions
Blood (5–10 ml) was obtained from healthy non-smoker adult individuals after
informed consent. Human erythrocytes from citrated blood were immediately iso-
lated by centrifugation at 1500 rpm for 10 min at 4 C. After removal of plasma andbuffy coat, the erythrocytes were washed three times with phosphate-buffered sal-
ine (PBS; pH 7.4) at 4 C, and, ﬁnally, resuspended in PBS to obtain erythrocyte sus-
pensions at 2% or 5.2% hematocrit.
2.4.2. Inhibitory efﬁciency of propolis extracts on AAPH-induced lipid peroxidation
Bornes and Fundão propolis extracts were initially solubilized in an amount of
dimethylsulfoxide (DMSO) to obtain 50 mg extract/ml stock solutions and further
diluted in PBS to obtain ﬁnal concentrations of 5, 10, and 20 lg extract/ml for Bor-
nes propolis and 10, 20 and 40 lg extract/ml for Fundão propolis. From these serial
dilutions, the DMSO ﬁnal concentration was never higher than 0.08%. In order to in-
duce free-radical chain oxidation in erythrocytes, aqueous peroxyl radicals were
generated by thermal decomposition of AAPH (ﬁnal concentration of 50 mM in
PBS). To study the protective effects of propolis extracts against AAPH-induced lipid
peroxidation, an erythrocyte suspension at 5.2% hematocrit was preincubated with
the extracts of Bornes or Fundão propolis at 37 C for 30 min, followed by incuba-
tion with and without 50 mM AAPH. The extention of lipid peroxidation was esti-
mated by HPLC-UV quantiﬁcation of malondialdehyde (MDA), as previously
described (Soares et al., 2004). Brieﬂy, 250 ll of erythrocyte suspensions were taken
at time 3 h and added to 25 ll of 0.2% BHT (in order to prevent further lipid perox-
idation) and 1 ml of 1% TCA. The samples were then vortexed, centrifuged
(10,000 rpm for 10 min, at 4 C), and 500 ll of 1% TBA was added to equal volume
of supernatant layer and allowed to stand at 95 C during 45 min. After cooling at
4 C, the samples were vortexed brieﬂy, centrifuged, and 50 ll of supernatants were
injected on a HPLC system equipped with UV detector (Hewlett Packard 1100 ser-
ies) set at 532 nm. Chromatographic separation was carried out using a Waters
Spherisorb C18, 5 lm ODS2 (4.6  250 mm analytical cartridge) from Waters Cor-
poration. The mobile phase consisted of methanol: ammonium acetate buffer
0.05 M (pH 5.5), at a solvent ﬂow rate of 0.7 ml/min. TEP standards in a concentra-
tion range 0.25–10 lM were used to obtain the standard curve calibration and the
results were expressed as lM MDA equivalents. The 50% inhibitory concentration
(IC50) was calculated from concentration–response curve obtained by plotting the
percentage of lipid peroxidation inhibition versus the extract concentration. Inhibi-
tion percentage values were calculated considering as 100% the value of lipid per-
oxidation induced by AAPH in the absence of the extracts. Three independent
experiments were used for these calculations.
2.4.3. Protective effect of propolis extracts on AAPH-induced hemolysis
The assays were performed using an erythrocyte suspension at 2% hematocrit.
The cells were preincubated at 37 C for 30 min in the presence of the chosen con-
centrations of Bornes (5–20 lg extract/ml) or Fundão propolis (10–40 lg extract/
ml), and then 50 mM AAPH solution was added. This reaction mixture was shaken
gently while being incubated at 37 C for 4 h. In all experiments, a negative control
(erythrocytes in PBS), as well as extract controls (erythrocytes in PBS with each ex-
tract) were used.
The extent of hemolysis was determined spectrophotometrically according to a
method reported before (Ko et al., 1997). Brieﬂy, aliquots of the reaction mixture
were taken out at each hour of the 4 h of incubation, diluted with saline, and cen-
trifuged at 4000 rpm for 10 min to separate the erythrocytes. The percentage of
hemolysis was determined by measuring the absorbance of the supernatant (A)
at 545 nm and compared with that of complete hemolysis (B) by treating an aliquot
with the same volume of the reaction mixture with distilled water. The hemolysis
percentage was calculated using the formula: A/B  100. IC50 values at time 3 h
were also determined from concentration–response curve obtained by plotting
the percentage of hemolysis inhibition versus the extract concentration. Ascorbic
acid was used as the reference antioxidant compound. Four independent experi-
ments were used for these calculations.
2.5. Antitumoral activity assessment
2.5.1. Isolation and primary cultures of normal and cancerous renal cells
Human kidney tissue samples were obtained from consenting patients under-
going radical nephrectomy for renal cell carcinoma at the Portuguese Oncology
Institute-Porto. Tissue samples were collected from areas deﬁned as normal (in
the cortex) or tumoral by an expert uropathologist. Renal cell isolation took place
immediately after sample collection as previously described by Carvalho et al.
(2002) with some modiﬁcations. Brieﬂy, after removing the renal capsule, tissue
was minced ﬁnely and then submitted to 1 mg/ml collagenase (type II) digestion.
Isolated renal cells were subsequently puriﬁed by sequential ﬁltration through
100, 70 and 40 lm sieves. Renal cells were then seeded in culture ﬂasks
(5  104 cells/cm2) and incubated at 37 C in a humidiﬁed incubator with 5% CO2.
The culture medium was DMEM/F12 supplemented with 10% FBS, 50 lg/ml penicil-
lin–streptomycin, 2.5 lg/ml fungizone, and 5 lg/ml human transferrin. Culture
medium was changed after 24 h and every 48 h thereafter. All cells were studied
after no more than three passages.
2.5.2. A-498 cell line
Human renal epithelial cancer cells A-498 (ATCC HTB-44) were cultured in
RPMI 1640 medium GlutaMax™ with 25 mM N-2-hydroxyethylpiperazine-N0-2-
ethanesulfonic acid (HEPES) containing 10% FBS, 100 lg/ml penicillin–streptomy-
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Fig. 1. Effect of propolis extracts from Bornes and Fundão regions on AAPH-induced
lipid peroxidation. Erythrocyte suspension at 5.2% hematocrit was incubated with
PBS (control) or preincubated with the extracts at the indicated concentrations for
30 min at 37 C. The cell suspension was then incubated with 50 mM AAPH for 3 h
at 37 C. Values are expressed as mean ± SD of four independent experiments.
*Represents signiﬁcant results (P < 0.05) when the treated group was compared
with the AAPH group.
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(5  104 cells/cm2) in a humidiﬁed incubator at 37 C with an atmosphere of
5% CO2.
2.5.3. Cytotoxicity of propolis extracts in primary cultured normal renal cells
Primary normal renal cells were subcultured at 5  103 cells per well on 96-well
plates at 37 C in a humidiﬁed atmosphere containing 5% CO2. As judged by light
microscopy, monolayers reached conﬂuency 4–5 days after plating. The cells were
then incubated for 24 h with different concentrations of Fundão and Bornes propo-
lis. Each extract was initially solubilized in an amount of absolute ethanol to obtain
20 mg extract/ml stock solutions and further diluted in medium to obtain ﬁnal con-
centrations of 100, 50, 25, and 10 lg of extract/ml. From these serial dilutions, the
ethanol ﬁnal concentration was never higher than 0.5% and the same concentration
was used for solvent-control wells. Cell viability was measured using the mitochon-
drial MTT assay. MTT is a yellow water-soluble dye that is reduced in viable cells to
an insoluble purple coloured product, MTT-formazan by the mitochondrial enzyme
succinate dehydrogenase. At the end of exposure time, the medium was removed
and the cells were washed once with fresh culture medium. Subsequently the cul-
tures were incubated at 37 C in a humidiﬁed atmosphere containing 5% CO2 for 1 h
with 200 ll of 0.5 mg/ml MTT (ﬁnal concentration). MTT solution was then re-
moved and formazan contained in cells was solubilized with 100 ll DMSO. The ex-
tent of reduction of MTT to formazan was quantiﬁed through the measurement of
absorbance at 550 nm in a microplate reader. Cell viability was measured as the
percentage of absorbance compared to control. Data are expressed as mean ± SEM
of three independent experiments performed in quadruplicate.
2.5.4. Growth inhibitory activity of propolis extracts in cancerous renal cells
Primary cultures of human cancerous renal cells and A-498 cancer cell line were
used to study the antiproliferative properties of propolis extracts on RCC cells. After
trypsin detachment, cells were counted, subcultured at 5  103 cells per well on
96-well plates, and incubated at 37 C in a 5% CO2 environment to allow for cell
attachment. After 24 h of incubation, exponentially growing cells were treated with
Bornes or Fundão propolis extracts at ﬁnal concentrations of 10, 25, 50, or 100 lg/
ml. The plates were incubated for 48 h under the same conditions. At the end of the
exposure time, the antiproliferative activity of propolis extracts on the cancerous
cells was measured by evaluating cell viability using the MTT colorimetric assay,
as previously described. IC50 values, deﬁned as the amount of extract that inhibits
50% of cell growth, were calculated after 48 h of incubation from concentration–re-
sponse curves obtained by plotting the percentage of growth inhibition versus the
extract concentration. Data are expressed as mean ± SEM of three independent
experiments performed in quadruplicate.
2.6. Statistical analysis
Statistic analysis was performed using the Statistical Package for Social Sciences
(SPSS, version 16.0) for Windows. Comparisons between two groups were per-
formed by unpaired t-test. Multiple comparisons between more than two groups
were performed by one-way ANOVA supplemented with Tukey’s HSD post hoc test.
Signiﬁcance was accepted at P lower than 0.05.
3. Results and discussion
3.1. Portuguese propolis protects the human erythrocyte against free
radical damage
The erythrocyte membrane is rich in polyunsaturated fatty
acids that are highly susceptible to free radical-mediated peroxida-
tion. The addition of AAPH, a peroxyl radical (ROO) initiator, to
erythrocytes causes oxidation of lipids and proteins in cell mem-
brane and thereby induces hemolysis (Zou et al., 2001). Inhibition
of lipid peroxidation by antioxidant compounds is a very important
way by which they can mitigate the induction and/or propagation
of oxidative stress related diseases. Therefore, the AAPH-induced
oxidative damage on human erythrocytes provides a good experi-
mental model to evaluate the biological relevance of the antioxi-
dant activity of several compounds (Zou et al., 2001; Costa et al.,
2009; Carvalho et al., 2010).
In this study, the antioxidant properties of extracts from Portu-
guese propolis were initially evaluated by their efﬁcacy to inhibit
AAPH-induced peroxidation to erythrocyte membrane lipids. The
extent of lipid peroxidation was assessed by measuring the forma-
tion of MDA, a well-known carbonyl product of oxidative lipid
damage (Esterbauer et al., 1991). As shown in Fig. 1, the MDA lev-
els in the erythrocytes of the control group was low(0.049 ± 0.014 lM) at 3 h. When the erythrocytes were incubated
with propolis extracts in the absence of AAPH, MDA formation
was maintained at a background level similar to that of the control
group (AAPH untreated samples) (data not shown). As expected,
MDA level signiﬁcantly increased (by 2608% at 3 h) after incuba-
tion with 50 mM AAPH when compared to the respective control.
Under the oxidative action of AAPH, human erythrocytes treated
with propolis extracts signiﬁcantly decreased the AAPH effect
(P < 0.05) in a concentration-dependent manner. Treatment with
Bornes and Fundão propolis at the highest concentration for 3 h re-
duced MDA levels by 71% and 78%, respectively, over the AAPH-
treated cells. The IC50 values, deﬁned as the amount of extract that
inhibits 50% of AAPH-induced lipid peroxidation, were respectively
8.1 ± 2.3 and 9.7 ± 2.3 lg of extract/ml for Bornes and Fundão
propolis.
Peroxidation to membrane lipids (by disturbing the structural
lipid bilayer) may alter the membrane permeability and disrupts
ionic channels. Hence, the antioxidant effects of propolis extracts
in the erythrocyte membrane were also evaluated by the protec-
tion conferred by these extracts against hemolysis induced by
AAPH. Fig. 2 shows the AAPH-induced hemolysis in human eryth-
rocytes and the protective effects of Portuguese propolis extracts.
Erythrocytes incubated at 37 C as a 2% suspension in PBS were sta-
ble with little hemolysis observed within 4 h (3.7 ± 1.5%). When
AAPH was added to the suspension of erythrocytes, hemolysis
induction was time-dependent. The hemolysis is lagged, indicating
that endogenous antioxidants in the erythrocytes, namely glutathi-
one, tocopherol, ascorbate and enzymes, such as catalase and
superoxide dismutase, can efﬁciently quench radicals to protect
them against free radical-induced hemolysis, as described previ-
ously (Zou et al., 2001). Bornes and Fundão propolis signiﬁcantly
protected the erythrocyte membrane from hemolysis induced by
AAPH in a concentration- and time-dependent manner (Fig. 2A
and B, respectively), with IC50 values after 3 h of incubation of
6.3 ± 0.7 and 10.4 ± 2.7 lg of extract/ml, respectively. When the
cells were incubated with either 0.08% DMSO or the highest tested
concentration of each propolis extract in the absence of AAPH,
hemolysis was maintained at a background level similar to that
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Fig. 2. Effect of propolis extracts from (A) Bornes and (B) Fundão regions on AAPH-induced hemolysis in human erythrocytes. Erythrocyte suspension at 2% hematocrit was
preincubated with extracts at the indicated concentrations for 30 min at 37 C. The cell suspension was then incubated with 50 mM AAPH for 4 h at 37 C. In all experiments,
control erythrocytes (incubated with PBS only) and AAPH-treated erythrocytes (incubated with 50 mM AAPH) were used. Values are expressed as mean ± SEM of four
independent experiments.  Represents signiﬁcant results (P < 0.05) when the treated group was compared with the AAPH group, at the respective time; # represents
signiﬁcant results (P < 0.05) when the treated group was compared with the control group, at the respective time.
M.J. Valente et al. / Food and Chemical Toxicology 49 (2011) 86–92 89in the control samples (data not shown). In this study, the antihe-
molytic activity of ascorbic acid was also investigated since it is a
renowned antioxidant compound by the scientiﬁc community.
The IC50 value calculated for ascorbic acid after 3 h of incubation
was found to be 31.0 ± 5.6 lg/ml. Comparison of results based on
inhibitory efﬁciency shown statistically signiﬁcant differences
(P < 0.05) between propolis extracts and ascorbic acid. Moreover,
the antioxidant effect of propolis observed in this study was higher
than or comparable to that of green tea extract reported previously
by Costa et al. (2009) in the same experimental conditions. It is
therefore evidenced that Portuguese propolis is a powerful
antioxidant agent and may be used as a preventive medicine
against oxidative stress and damage to cellular molecules and
membranes, thus maintaining structural and functional integrity
of the cells.
The antioxidant properties of propolis extracts are certainly
related to its chemical composition. Many studies have evi-
denced the presence of ﬂavonoids (including ﬂavones, ﬂavonols,
ﬂavanones and dihydroﬂavonols) and other phenolics (mainly
substituted cinnamic acids and their esters) as main active con-
stituents of propolis possessing potent antioxidant activities
(Moreno, 2000; Kumazawa et al., 2004; Banskota et al., 2001b).
The samples of the present study were previously characterized
by Moreira et al. (2008) and, more recently, by Falcão et al.
(2010). It was shown that Portuguese propolis samples (from
Bornes and Fundão regions) contain considerable amounts of
polyphenolic compounds and possess effective DPPH radical
scavenging and reducing activities. In addition, Falcão et al.
(2010) reported for the ﬁrst time the phenolic proﬁle of theNortheast Portuguese propolis (from Bornes region). The most
abundant compounds in this matrix were those commonly found
in the phenolic extracts of propolis from temperate zones (Gar-
dana et al., 2007; Marcucci, 1995): it contained phenolic acids,
including caffeic, p-coumaric, ferulic and isoferulic acids, and
their esters, such as the caffeic acid benzyl ester, the caffeic acid
phenylethyl ester (CAPE), the caffeic acid isoprenyl ester and its
isomer, and the caffeic acid cinnamyl ester. In addition, ﬂavo-
noids previously described in propolis were also detected in
the Portuguese sample, i.e., dihydroﬂavonols, ﬂavones, ﬂavanon-
es, and ﬂavonols, either as free form or their methylated/esteri-
ﬁed forms. In particular, it was present the aglycones forms of
apigenin, pinobanksin, pinocembrin and chrysin, the esteriﬁed
derivatives pinobanksin-3-O-acetate, pinobanksin-3-O-propio-
nate, pinobanksin-3-O-butyrate or isobutyrate and pinobanksin-
3-O-pentanoate or 2-methylbutyrate, and the methylated deriva-
tives pinobanksin-5-methyl-ether, pinocembrin-5-methyl-ether,
chrysin-5-methyl-ether, and chrysin-6-methyl-ether (Falcão
et al., 2010). While the propolis sample from Bornes region has
already been extensively characterized, the phenolic proﬁle of
propolis from Fundão region remains unknown, but there is no
reason to believe that the main phenolic constituents are signif-
icantly different between the two samples. Work is currently in
progress to conﬁrm the chemical characterization of Fundão
propolis.
Polyphenolic compounds have been found to protect erythro-
cytes from oxidative stress or increase their resistance to damage
caused by oxidants (Kaviarasan et al., 2004; Asgary et al., 2005;
Biswas et al., 2005). They are able to act as antioxidants in a num-
90 M.J. Valente et al. / Food and Chemical Toxicology 49 (2011) 86–92ber of ways, mainly as reducing agents, hydrogen donors, singlet
oxygen quenchers, and metal chelating agents (Cao et al., 1997;
Rice-Evans et al., 1996). Therefore, propolis polyphenols present
in the incubation medium may quench peroxyl radicals in the
aqueous phase before the radicals attack the biomolecules of the
erythrocyte membrane to cause peroxidation and, ultimately,
hemolysis.
3.2. Portuguese propolis selectively inhibits the in vitro proliferation of
human RCC
Renal cell carcinoma (RCC) is the most lethal urologic cancer.
Symptoms arise late in the course of disease, hence approximately
50% of patients present with locally advanced or metastatic disease
and have poor prognosis due to the high resistance of RCC to cur-
rent chemotherapy and radiotherapy regimens (Motzer et al.,
2000). Therefore, the discovery of new strategies for therapeutic
intervention remains a priority. In this regard, natural products
have been largely explored over the past decades since they are ex-
pected to play an important role in creating new and effective che-
mopreventive and therapeutic agents.
Propolis has been extensively studied for its anticancer potential.
Inhibition of cell growth and the induction of apoptosis in different
cancer cell lines by propolis and its polyphenols have been reported
(Li et al., 2010; Sha et al., 2009; Usia et al., 2002). However, to the
best of our knowledge, the anticarcinogenic effect of propolis in
RCC cells has not been investigated yet. Therefore, the present study
was designed to evaluate the growth inhibitory activity of extracts
from Portuguese propolis in human RCC, using primary cultures of
malignant renal cells and A-498 cell line. Of major importance to
our study is that primary cell cultures isolated from human kidney
tissues were used, which have several distinct advantages over
immortalized cell lines. The renal primary cell cultures retain many
of phenotypic characteristics of the original tissue and, therefore,
can be highly relevant models for pharmacological evaluation of
sensitivity/toxicity and therapeutic responses. This in vitro model
can theoretically predict in vivo responses to a speciﬁc agent. In
addition, the use ofmultiple donors for samples of tissue to generate
independent isolates of primary cells allows researchers to demon-
strate consistent responses among individuals (Marshak and
Greenwalt, 2006).
Selectivity is also an important issue in cancer prevention and
therapy. Therefore, the cytotoxic effect of propolis extracts in hu-
man normal renal cells was also evaluated. The in vitro cytotoxic
and antiproliferative activities were determined using the MTT as-
say. Fig. 3 presents the concentration effectiveness of propolis ex-
tracts on the viability of primary cultured normal and cancerous
renal cells, and A-498 renal cancer cell line. Four different concen-
trations of each extract (10, 25, 50, and 100 lg/ml) were tested. Pa-
nel A shows that propolis extracts are weakly toxic to human
normal renal cells. In contrast, Fundão and Bornes propolis extracts
strongly and equally supressed the proliferation of primary renal
cancerous cells in a concentration-dependent manner, with 91
and 85% cell growth inhibition at a concentration level of 100 lg
of extract/ml (Fig. 3, Panel B). The IC50 values calculated for Fundão
and Bornes propolis in primary renal neoplastic cells were
56.5 ± 16.7 and 56.1 ± 20.9 lg of extract/ml, respectively. However,
in A-498 cell line, Bornes propolis extract exerted higher antiprolif-
erative activity than Fundão propolis (Fig. 3, Panel C). IC50 value ob-
tained for Bornes propolis was 70.8 ± 10.7 lg of extract/ml, while
for Fundão sample it was >100 lg of extract/ml. The different re-
sults obtained between Bornes and Fundão propolis are likely to
be explained by the higher amount of phenolic compounds present
in Bornes propolis (Moreira et al., 2008).
The inhibitory effect against renal cancer cell growth exhibited
by these propolis samples may be related to an overall effect ofthe phenolic compounds present in the extracts, being caffeic acid,
caffeic acid phenethyl ester (CAPE), quercetin, chrysin, apigenin,
kaempferol, kaempferid, and galangin the most promising as anti-
tumor agents (Orsolic´ et al., 2005). The antiproliferative activity of
ﬂavonoids, as well as that of hydroxycinnamic acids, on several
cancer cell lines is widely reported in the literature (Patel et al.,
2007; Marcucci, 1995; Li et al., 2008; Chen et al., 2004; Fresco
et al., 2006; Kawaii et al., 1999; Bankova, 2005). Among them,
CAPE has been identiﬁed as a major anticancer compound in
European propolis (Banskota et al., 2002). It has been reported
that human cancer cell lines displayed a signiﬁcantly greater sen-
sitivity to the action of CAPE than analogous normal lines (Chiao
et al., 1995; Frenkel et al., 1993), which is in accordance with
the cancer cell-selective toxicity exhibited by propolis extracts
in the present study. The antitumoral activity of benzyl, phenethyl
and cinnamyl caffeates isolated from propolis samples was re-
ported (Banskota et al., 2002; Jin et al., 2005; Usia et al., 2002).
However, other components present in propolis, such as terpe-
noids and waxy acids, may also exhibit inhibitory actions on can-
cer cell growth. For example, Pratsinis et al. (2010) showed that
manool, a diterpene isolated from Greek propolis, was the most
cytotoxic compound against HT-29 human colon adenocarcinoma
cells. Therefore, the anticancer activity of propolis may be attrib-
uted to a synergism between phenolic and other constituents in
the resin, rather than to the effect of a speciﬁc phytochemical or
a class of phytochemicals.
The present study shows, for the ﬁrst time, that propolis extract
markedly prevented the proliferation of human RCC cells in vitro.
However, the molecular mechanisms for these anticancer actions
are not fully understood. As referred before, phenolic compounds
present in propolis are known to possess antioxidant properties,
and these properties may play a key role in the anticancer activi-
ties. It has been suggested that antiproliferative activities of caffeic
acid derivatives (mainly CAPE) present in propolis may be related
to its modulation of oxidative processes in cells (Banskota et al.,
2002; Usia et al., 2002). However, the antioxidant properties of
these phenolic compounds may not entirely explain their chemo-
preventive effects. Recent studies showed that CAPE inhibits the
proliferation of hepatocarcinoma cell lines Hep3B and SK-Hep1
through inhibition of matrix metalloproteinase (MMP)-2 and
MMP-9 activity (Lee et al., 2008; Jin et al., 2005). MMPs are a family
of zinc-dependent neutral endopeptidases that elicit degradation
of the extracellular matrix and basement membranes, ultimately
leading to tumoral progression. Other mechanisms include inhibi-
tion of angiogenesis (Kunimasa et al., 2009) and metastasis
(Hwang et al., 2006), cell-cycle arrest (Pratsinis et al., 2010), and
induction of growth arrest and apoptosis through regulation of
multiple signaling pathways (Chen et al., 2004; Bufalo et al.,
2010; Fresco et al., 2006; Orsolic´ et al., 2005).
In conclusion, this work presents the ﬁrst report on the bio-
logical activities of Portuguese propolis. Using human erythro-
cytes as a cellular model, we demonstrated that propolis
extracts at very low concentrations can inhibit or reduce lipid
peroxidation and hemolysis induced by peroxyl radicals. In addi-
tion, the results of this study represent the ﬁrst evidence that
propolis displays effective antiproliferative activity against hu-
man renal cancer cells. Furthermore, the comparison of the
in vitro responses of normal and malignant cells to propolis ex-
tracts revealed that cancerous cells were more sensitive in terms
of growth inhibition than normal cells. Overall, these ﬁndings
support Portuguese propolis as a promising therapeutic agent
in the prevention of diseases mediated by free radicals and par-
ticularly in the chemoprevention of RCC. Additional studies in
animal models and clinical trials are required to fully evaluate
the potential of propolis in the prevention and/or treatment of
kidney cancer.
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Fig. 3. Concentration effectiveness of propolis extracts from Bornes and Fundão regions on cell viability of (A) primary cultured normal renal cells, (B) primary cultured
cancerous renal cells, and (C) A-498 cancer cell line. Four concentrations of extracts (10, 20, 50, and 100 lg of extract/ml) were applied. Values are presented as mean ± SEM of
three independent experiments performed in quadruplicate.  Represents signiﬁcant results (P < 0.05) when the treated group was compared with the control group.
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